According to filings with the U.S. Securities and Exchange Commission, i2 Health Advisors is raising up to $3,500,000.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

About i2 Health Advisors
i2 Health Advisors is a solutions partner for health plans that want results, not just roadmaps. The company extends investments in established technology platforms into AI enabled infrastructure that modernizes and transforms operational workflows. i2 Health Advisors partners closely with clients to make work faster, smarter, and more scalable.

To learn more, visit https://www.i2health.com/
LinkedIn: https://www.linkedin.com/company/i2health/

Contact:
Anders Brown, Chief Executive Officer

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.